FDA Clearance Tracker · P020024-S038
AMPLATZER DUCT OCCLUDER (ADO)
Last checked: Nov 20, 2026Latest source record: Oct 29, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Oct 29, 2014
Approved
Time to decision
630 days
Received Feb 6, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020024-S038
- Device name
- AMPLATZER DUCT OCCLUDER (ADO)
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Feb 6, 2013
- Decided
- Oct 29, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020024
Device type
- Device type
- OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CONVERTING THE NITINOL WIRE USED IN THE MANUFACTURE OF THESE DEVICES FROM A BLACK OXIDE SURFACE FINISH TO A CHEMICALLY ETCHED SURFACE FINISH.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.